ASRT Stock Analysis: Buy, Sell, or Hold?
ASRT - Assertio Holdings, Inc. Common Stock
$12.24
0.46 (3.90%)
▲
5d:
+1.07%
30d:
+34.95%
90d:
+1527.66%
HOLD
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Mar 11, 2026
Get Alerted When ASRT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ASRT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ASRT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$20.74
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$12.88
5.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ASRT is currently trading at $12.24, which is considered extended relative to its 30-day fair value range of $9.43 to $11.75. From a valuation perspective, the stock is trading at a premium (Forward PE: 8.2) compared to its historical average (7.1). At these levels, the market is pricing in 4.7% annual earnings growth.
Technical Outlook: Technically, ASRT is in a strong uptrend. The price is approaching resistance at $12.54. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $37.44 (+205.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ASRT is in a strong uptrend. The price is approaching resistance at $12.54. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $37.44 (+205.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$9.43 -
$11.75
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
59.0%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.9%)
- BULLISH: Trading 205.9% below Wall St target ($37.44)
- BULLISH: Expecting earnings turnaround to 4.7% growth with 69.4% revenue growth
Fair Price Analysis
30-Day Fair Range
$9.43 -
$11.75
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$11.04
Resistance Level
$12.54
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
8.16
Wall Street Target
$37.44
(+205.9%)
Revenue Growth (YoY)
69.4%
Earnings Growth (YoY)
-18.8%
Profit Margin
-21.1%
Valuation Premium vs History
+4.7% premium
PE vs Historical
8.2 vs 7.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.7%
(market-implied from PE analysis)
1-Year Target
$12.82
(+5%)
2-Year Target
$13.42
(+10%)
3-Year Target
$14.05
(+15%)
3-Yr Target (if PE normalizes)
(PE: 8→7)
PE COMPRESSION
$12.22
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 150.0%)
$112.89
(+822%)
Base:
(SPY PE: 8.2, Growth: 150.0%)
$41.31
(+238%)
Bear:
(PE: 6.9, Growth: 150.0%)
$35.11
(+187%)
Last updated: February 02, 2026 4:04 PM ET
Data refreshes hourly during market hours. Next update: 5:04 PM
Data refreshes hourly during market hours. Next update: 5:04 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ASRT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$180 | 60 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$154 | 56 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$83 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 54 HOLD |
